SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-009095
Filing Date
2023-03-20
Accepted
2023-03-20 16:05:17
Documents
1
Period of Report
2023-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3737
  Complete submission text file 0000899243-23-009095.txt   5071
Mailing Address P.O. BOX 134 MALVERN PA 19355
Business Address P.O. BOX 134 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Issuer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GALERA THERAPEUTICS, INC. 2 W LIBERTY BOULEVARD, #110 MALVERN PA 19355
Business Address
Bachleda Mark (Reporting) CIK: 0001887762 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39114 | Film No.: 23746416